Casdin Capital’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.4M | Buy |
11,398,574
+2,300,000
| +25% | +$7.96M | 3.59% | 8 |
|
|
2025
Q1 | $23.8M | Buy |
9,098,574
+150,000
| +2% | +$393K | 1.95% | 11 |
|
|
2024
Q4 | $36.9M | Sell |
8,948,574
-302,534
| -3% | -$1.25M | 2.45% | 9 |
|
|
2024
Q3 | $65.5M | Buy |
9,251,108
+802,534
| +9% | +$5.68M | 4.37% | 8 |
|
|
2024
Q2 | $55.1M | Buy |
8,448,574
+1,025,000
| +14% | +$6.68M | 4.21% | 7 |
|
|
2024
Q1 | $61.6M | Buy |
7,423,574
+35,631
| +0.5% | +$296K | 4.58% | 5 |
|
|
2023
Q4 | $81.3M | Buy |
7,387,943
+464,369
| +7% | +$5.11M | 7.98% | 4 |
|
|
2023
Q3 | $58.2M | Buy |
6,923,574
+925,000
| +15% | +$7.78M | 6.44% | 5 |
|
|
2023
Q2 | $75.3M | Buy |
5,998,574
+300,000
| +5% | +$3.77M | 6.58% | 3 |
|
|
2023
Q1 | $93.9M | Buy |
5,698,574
+2,667,926
| +88% | +$43.9M | 7.73% | 3 |
|
|
2022
Q4 | $45.3M | Sell |
3,030,648
-1,652,784
| -35% | -$24.7M | 3.51% | 9 |
|
|
2022
Q3 | $105M | Buy |
4,683,432
+614,858
| +15% | +$13.8M | 6.88% | 7 |
|
|
2022
Q2 | $68.1M | Buy |
4,068,574
+211,321
| +5% | +$3.54M | 5.76% | 4 |
|
|
2022
Q1 | $115M | Hold |
3,857,253
| – | – | 5.18% | 5 |
|
|
2021
Q4 | $118M | Buy |
3,857,253
+188,679
| +5% | +$5.79M | 3.34% | 13 |
|
|
2021
Q3 | $116M | Buy |
3,668,574
+293,516
| +9% | +$9.25M | 2.88% | 11 |
|
|
2021
Q2 | $123M | Hold |
3,375,058
| – | – | 3.13% | 11 |
|
|
2021
Q1 | $117M | Sell |
3,375,058
-433,836
| -11% | -$15M | 3.48% | 9 |
|
|
2020
Q4 | $158M | Hold |
3,808,894
| – | – | 4.69% | 6 |
|
|
2020
Q3 | $162M | Buy |
+3,808,894
| New | +$162M | 7.26% | 3 |
|